With the world digestive health market estimated at $44.4 billion in 2022 and microbiome subcategories forecasted to grow at a rate of 6 to 10% by 2027 to 2029, formulators are increasingly looking for powerful, clinically supported, probiotic and postbiotic ingredients.
Four great examples of these are LAC-Shield, Morinaga BB536, Morinaga M-16V and Morinaga M-63.
The Immunity Defender
LAC-Shield™ (Lactobacillus paracasei MCC1849) is a heat-killed and highly stable postbiotic strain of beneficial lactic acid bacteria that has significantly more immune activity than other strains of lactic acid bacteria.*
Click here for the LAC-Shield Infographic
Mechanism of Action
LAC-Shield exerts beneficial effects on the immunocytes in the small intestine Peyer’s patch to produce immunologically active proteins, in this way stimulating antibody production promoter cells to produce antibodies.*
It has been shown to exhibit significant benefits in inducing the production of interleukin-12 (IL-12), a powerful activator of innate and adaptive immunity.*
Intake of LAC-Shield helps maintain and support a healthy immune system generally, reducing discomfort that may be occasionally associated with common cold.*
LAC-Shield has no stability issues related to harsh manufacturing conditions, ambient temperature or heat, and gastrointestinal transit.
LAC-Shield is Self-Affirmed GRAS, gluten-free, dairy-free, Kosher, Halal and non-GMO.
Contact a Maypro Representative
One of the World’s Most Researched Probiotics
Morinaga BB536® is a proprietary room-temperature and stable strain of Bifidobacterium longum commonly found in the human intestine.
It is easily one of the most researched, and effective, probiotic strains, one that is supported by over 50 published human clinical studies.
Mechanism of Action
Numerous studies, including double-blind, placebo-controlled human clinical trials, have shown that Morinaga BB536 aids digestive health and comfort by significantly:*
- Supporting a healthy balance of bacteria in the gastro-intestinal tract*
- Increasing short chain fatty acids*
Morinaga BB536 owes its efficacy to the fact that it increases levels of bifidobacteria in the human gut — and that it is stable enough to reach the intestines alive.
Levels of this bifidobacterium decline with age, making supplementation a wise consumer choice. Clinical studies show that Morinaga BB536 encourages a healthy immune system and:
- Helps with digestive regularity*
- Supports natural detoxification*
- Promotes balance of healthy bacteria*
- Discourages harmful strains of bacteria*
- Supports healthy cholesterol levels already in a proper range*
Self-affirmed GRAS Morinaga BB536 is dairy-free, gluten-free, Halal, and non-GMO
Winner of the 2019 NutraIngredients Asia Award for Ingredient of the Year (Infant Nutrition), Morinaga M-16V® is a room-temperature stable strain of Bifidobacterium breve supported by over 30 published studies, including 19 human clinical trials.
Mechanism of Action
Morinaga M-16V is believed to work through a number of ways to protect the health of children and infants, including:
- Supporting the health of the gastro-intestinal mucosal layer*
- Modulating the immune response through acting on T-helper cells, immunoglobulin E and galectin-9*
Published scientific studies have shown that in children and/or babies, including low-birth-weight infants, Morinaga M-16V:
- Restores bifidobacterium to normal levels*
- Supports a healthy immune system*
- Promotes respiratory health*
- Supports skin health*
Morinaga M-16V is Self-Affirmed GRAS for food applications and infant formulas.
M-16V is dairy-free, Halal, and non-GMO.
An Infant Nutrition Powerhouse
Morinaga M-63 is a clinically backed, room-temperature stable strain of Bifidobacterium infantis that helps establish healthy microflora in low-birth-weight infants.*
Mechanism of Action
Bifidobacterium infantis is so-named because it is a commonly found species of bifidobacteria in the infant gut.* Research on this species has shown it has abundant gene clusters for utilizing human milk oligosaccharides, which may contribute to its effective colonization in low-birth-weight infants.*
A study published in the journal Anaerobe found that low-birth-weight infants given a mix of three bifidobacteria species, including Morinaga M-63, achieved healthy colonization of microflora more quickly than those infants given no probiotics or only one species.* In fact, after just one week, the rate of detection of bifidobacterium in the three-species group was 100%, compared to 57% in the one-species group and 14% in the control group.*
A recent study showed that consumption of B. infantis M-63 can effectively improve mental well-being through the change in the ratio of gut microbiota, in this way acting as a psychobiotic.*
M-63 is dairy-free, Halal, Kosher, DSHEA and non-GMO.
Contact a Maypro Representative
EVENTS
Visit Maypro at VitaFoods Europe
Schedule some time with our Global Export team at Vitafoods Europe. It is the perfect opportunity to share updates on your newest products in development and ingredient needs. Be sure to ask about our global sourcing capabilities and the latest research on our European ingredient portfolio.
Vitafoods Europe
May 9-11, 2023
Palexpo
Stand K50
Let’s work together to make the world a healthier, happier place.
